P00451 (FA8_HUMAN) Homo sapiens (Human)
Coagulation factor VIII UniProtKBInterProSTRINGInteractive Modelling
2351 aa; Sequence (Fasta) ; (Isoform 2)
Available Structures
23 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
Crystal Structure Analysis of Coagulation Factor VIII |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 3×CA; 2×CU; | ||||
Assess | ||||||
Crystal structure of human factor VIII |
Heteromer | 1×NAG; 1×NAG; 2×CU; 1×CA; 2×NAG; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII |
Heteromer | 1×NAG; 1×NAG; 1×ZN; 1×CA; 2×EDO; 1×CU1; | ||||
Assess | ||||||
Model of membrane-bound factor VIII organized in 2D crystals |
Heteromer | 1×NAG; 1×NAG; 2×CU; 1×CA; 2×NAG; | ||||
Assess | ||||||
Crystal structure of rFVIIIFc |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 3×CA; 2×CU; | ||||
Assess | ||||||
rFVIIIFc-VWF-XTEN (BIVV001) |
Heteromer P04275; | 1×NAG; 3×NAG; 2×CA; 1×ZN; 1×CU; | ||||
Assess | ||||||
Structure of Blood Coagulation Factor VIII in Complex with an Anti-C1 Domain Pathogenic Antibody In… |
Heteromer P12263; | 1×NAG; 1×NAG; 1×NAG; 1×CU; 1×CA; 1×ZN; | ||||
Assess | ||||||
Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor |
Heteromer P12263; | 2×NAG; | ||||
Assess | ||||||
Cryo-EM structure of coagulation factor VIII bound to NB2E9 |
Heteromer P12263; | 3×NAG; | ||||
Assess | ||||||
Factor VIII in complex with the anti-C2 domain antibody, G99 |
Heteromer P12263; | 2×NAG; 1×NAG; 1×CU; 1×ZN; 1×CA; | ||||
Assess | ||||||
Human Factor VIII C2 Domain complexed to human monoclonal BO2C11 Fab. |
Heteromer | |||||
Assess | ||||||
Cystal structure of human factor VIII C2 domain in a ternary complex with murine inhbitory antibodi… |
Heteromer | |||||
Assess | ||||||
Crystal Structure of the Human Factor VIII C2 Domain in Complex with Murine 3E6 Inhibitory Antibody |
Heteromer | 2×MG; | ||||
Assess | ||||||
Crystal Structure Determination of Human/Porcine Chimera Coagulation Factor VIII | homo-2-mer | 3×NAG; 1×NAG; 1×NAG; 1×NAG; 2×CA; 2×ZN; 2×CU1; | ||||
Assess | ||||||
Improved Model of Human Coagulation Factor VIII | monomer | 3×NAG; 1×CA; 1×ZN; 1×CU1; | ||||
Assess | ||||||
Membrane-bound factor VIII light chain | monomer | |||||
Assess | ||||||
Crystal structure of the c2 domain of human factor viii at 1.5 a resolution at 1.5 A | monomer | 2×SO4; 1×CYS; 1×GOL; | ||||
Assess | ||||||
Factor VIII Trp2313-His2315 segment is involved in membrane binding as shown by crystal structure o… | monomer | |||||
Assess | ||||||
Factor VIII Trp2313-His2315 segment is involved in membrane binding as shown by crystal structure o… | monomer | 1×768; | ||||
Assess | ||||||
Factor VIII Trp2313-His2315 segment is involved in membrane binding as shown by crystal structure o… | monomer | |||||
Assess | ||||||
The discobody: an engineered discoidin domain from factor VIII that binds v 3 integrin with antibod… | monomer | |||||
Assess | ||||||
MEMBRANE-BINDING PEPTIDE FROM THE C2 DOMAIN OF FACTOR VIII FORMS AN AMPHIPATHIC STRUCTURE AS DETERM… | monomer | |||||
Assess | ||||||
COAGULATION FACTOR VIII, NMR, 1 STRUCTURE | monomer | |||||
Assess |
3 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
7kwo.1.A | monomer | 0.54 | 1×CA; 1×ZN; 1×CU; | 86.18 | ||
Assess | ||||||
6mf2.1.A | monomer | 0.53 | 1×CA; 1×ZN; 1×CU1; | 96.83 | ||
Assess | ||||||
6mf0.2.A | monomer | 0.53 | 1×CA; 1×ZN; 1×CU1; | 88.61 | ||
Assess |
3 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 6mf0.2.A | monomer | 0.73 | 98.11 | ||
Assess | ||||||
Isoform 2 | 3j2s.1.A | monomer | 0.71 | 98.11 | ||
Assess | ||||||
Isoform 2 | 3j2q.1.B | monomer | 0.69 | 98.11 | ||
Assess |